Project Grant R01HL177055
Award Date
4/1/25
Completion Date
1/31/30
Dollars Obligated
$705K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This $735,346 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund the development of an AI-powered, equitable, interpretable, and generalizable cardiovascular disease (CVD) risk prediction model. The primary awardee is the University of Massachusetts Medical School, which will partner with community health centers and academic hospitals to integrate clinical factors and multi-domain social...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 5-year, $1,584,184 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center to develop deep learning algorithms that can precisely characterize mitral valve disease and identify accelerated cardiovascular risk trajectories. The researchers will leverage echocardiography data from both healthcare and community-based cohorts to train and validate AI models that can automate the phenotyping of...
This federal Project Grant award of $688,291 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development and clinical validation of a novel 3D ultrasound-based technique called Electromechanical Wave Imaging (EWI) for non-invasive cardiac arrhythmia mapping. The research team at Columbia University's Health Sciences Division will validate the 3D EWI technique against invasive high-density electrical...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $791,113 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Cedars-Sinai Medical Center. The grant, entitled "Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress," will leverage advanced artificial intelligence (AI) techniques applied to echocardiography imaging data to predict biological cardiovascular age and identify contributors to accelerated versus delayed cardiovascular...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will develop, validate, and determine the clinical utility of a precision genetic testing approach guided by machine learning algorithms. The $756,895 award to Duke University, with sub-awards to Mayo Clinic and the Medical University of South Carolina, aims to enhance the diagnosis of two monogenic cardiovascular disorders: hypertrophic...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $810,650 to Cedars-Sinai Medical Center to develop and validate an artificial intelligence (AI)-enabled algorithm for automated quantification of fibrotic and calcific aortic valve tissue characteristics from standard computed tomography angiography (CTA). The goal is to predict rapid aortic valve disease progression and...
This $760,046 federal Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) supports the development of a computationally-efficient multiscale modeling framework that integrates machine learning and artificial intelligence to predict structural and functional changes in the heart due to disease progression. The project aims to build fundamental understanding of heart disease by combining techniques from...
This federal Project Grant award, with ID R21HL172209, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $117,375 grant, awarded on August 1, 2024, will support research by Emory University to apply machine learning and time-series analysis of electrocardiogram (ECG) data to identify longitudinal changes that could serve as biomarkers for predicting the need for cardiac intervention or the occurrence of...
This $656,751 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) funds the development of an artificial intelligence (AI)-based platform called TCDFLOW by Third Coast Dynamics, Inc. The platform aims to provide 4D hemodynamic assessment of thoracic aortic aneurysms directly from routine clinical anatomic images, without the need for specialized 4D flow MRI techniques and expertise. The two-phase...
This $753,813 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop personalized prediction models for cardiovascular outcomes using machine learning analysis of cardiac MRI data and genomics. The primary awardee, Yale University, will use convolutional neural networks to identify MRI features that can accurately predict the presence of clonal hematopoiesis of indeterminate potential (CHIP) and predict...